In This Article:
RICHMOND, Calif. (AP) — RICHMOND, Calif. (AP) — Sangamo Therapeutics Inc. (SGMO) on Monday reported a loss of $23.4 million in its fourth quarter.
On a per-share basis, the Richmond, California-based company said it had a loss of 11 cents.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.
The drug developer posted revenue of $7.6 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $15.9 million.
For the year, the company reported a loss of $97.9 million, or 49 cents per share. Revenue was reported as $57.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO